BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11160128)

  • 1. Sarcoglycan, the heart, and skeletal muscles: new treatment, old drug?
    Towbin JA; Bowles NE
    J Clin Invest; 2001 Jan; 107(2):153-4. PubMed ID: 11160128
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex.
    Cohn RD; Durbeej M; Moore SA; Coral-Vazquez R; Prouty S; Campbell KP
    J Clin Invest; 2001 Jan; 107(2):R1-7. PubMed ID: 11160141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcoglycans in muscular dystrophy.
    Hack AA; Groh ME; McNally EM
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):167-80. PubMed ID: 10679964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathogenesis of muscle degeneration in the delta-sarcoglycan-deficient hamster.
    Straub V; Duclos F; Venzke DP; Lee JC; Cutshall S; Leveille CJ; Campbell KP
    Am J Pathol; 1998 Nov; 153(5):1623-30. PubMed ID: 9811355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel.
    Iwata Y; Katanosaka Y; Arai Y; Komamura K; Miyatake K; Shigekawa M
    J Cell Biol; 2003 Jun; 161(5):957-67. PubMed ID: 12796481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutations.
    Barresi R; Di Blasi C; Negri T; Brugnoni R; Vitali A; Felisari G; Salandi A; Daniel S; Cornelio F; Morandi L; Mora M
    J Med Genet; 2000 Feb; 37(2):102-7. PubMed ID: 10662809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex.
    Hack AA; Lam MY; Cordier L; Shoturma DI; Ly CT; Hadhazy MA; Hadhazy MR; Sweeney HL; McNally EM
    J Cell Sci; 2000 Jul; 113 ( Pt 14)():2535-44. PubMed ID: 10862711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E.
    Durbeej M; Cohn RD; Hrstka RF; Moore SA; Allamand V; Davidson BL; Williamson RA; Campbell KP
    Mol Cell; 2000 Jan; 5(1):141-51. PubMed ID: 10678176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of adhalin in a patient with muscular dystrophy and cardiomyopathy.
    McNally EM; Bönnemann CG; Kunkel LM; Bhattacharya SK
    N Engl J Med; 1996 Jun; 334(24):1610-1. PubMed ID: 8628353
    [No Abstract]   [Full Text] [Related]  

  • 10. Sequential expression of genes involved in muscular dystrophies during human development.
    Durand M; Suel L; Barbet JP; Beckmann JS; Fougerousse F
    Morphologie; 2002 Jun; 86(273):9-12. PubMed ID: 12224393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. epsilon-sarcoglycan replaces alpha-sarcoglycan in smooth muscle to form a unique dystrophin-glycoprotein complex.
    Straub V; Ettinger AJ; Durbeej M; Venzke DP; Cutshall S; Sanes JR; Campbell KP
    J Biol Chem; 1999 Sep; 274(39):27989-96. PubMed ID: 10488149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant deficiency of beta- and gamma-sarcoglycans in 20 alpha-sarcoglycan (adhalin)-deficient patients: immunohistochemical analysis and clinical aspects.
    Barresi R; Confalonieri V; Lanfossi M; Di Blasi C; Torchiana E; Mantegazza R; Jarre L; Nardocci N; Boffi P; Tezzon F; Pini A; Cornelio F; Mora M; Morandi L
    Acta Neuropathol; 1997 Jul; 94(1):28-35. PubMed ID: 9224527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary coronary artery vasospasm promotes cardiomyopathy progression.
    Wheeler MT; Korcarz CE; Collins KA; Lapidos KA; Hack AA; Lyons MR; Zarnegar S; Earley JU; Lang RM; McNally EM
    Am J Pathol; 2004 Mar; 164(3):1063-71. PubMed ID: 14982859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcoglycan complex: a muscular supporter of dystroglycan-dystrophin interplay?
    Matsumura K; Saito F; Yamada H; Hase A; Sunada Y; Shimizu T
    Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):751-62. PubMed ID: 10541473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of the 50 kDa dystrophin-associated-glycoprotein (adhalin) in an Indian autosomal recessive limb girdle muscular dystrophy patient : immunochemical analysis and clinical aspects.
    Handa V; Mital A; Gupta M; Goyle S
    Neurol India; 2001 Mar; 49(1):19-24. PubMed ID: 11303236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The frequency of patients with adhalin deficiency in a muscular dystrophy patient population].
    Hayashi YK; Arahata K
    Nihon Rinsho; 1997 Dec; 55(12):3165-8. PubMed ID: 9436429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific assembly pathway of sarcoglycans is dependent on beta- and delta-sarcoglycan.
    Shi W; Chen Z; Schottenfeld J; Stahl RC; Kunkel LM; Chan YM
    Muscle Nerve; 2004 Mar; 29(3):409-19. PubMed ID: 14981741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12.
    Lim LE; Duclos F; Broux O; Bourg N; Sunada Y; Allamand V; Meyer J; Richard I; Moomaw C; Slaughter C
    Nat Genet; 1995 Nov; 11(3):257-65. PubMed ID: 7581448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strain- and age-dependent loss of sarcoglycan complex in cardiomyopathic hamster hearts and its re-expression by delta-sarcoglycan gene transfer in vivo.
    Kawada T; Nakatsuru Y; Sakamoto A; Koizumi T; Shin WS; Okai-Matsuo Y; Suzuki J; Uehara Y; Nakazawa M; Sato H; Ishikawa T; Toyo-oka T
    FEBS Lett; 1999 Sep; 458(3):405-8. PubMed ID: 10570949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional nitric oxide synthase mislocalization in cardiomyopathy.
    Heydemann A; Huber JM; Kakkar R; Wheeler MT; McNally EM
    J Mol Cell Cardiol; 2004 Feb; 36(2):213-23. PubMed ID: 14871549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.